Drug Delivery Infusion Systems are used to administer medications and fluids to critically ill patients by infusion. The Drug Delivery Infusion Systems market was estimated at USD 9 billion in 2017.
The market is driven by the increased prevalence of chronic diseases such as cancer and diabetes coupled with rising demand for improved patient care. As a result, the market will witness increased usage across different therapeutic indication over the forecast period. However, factors concerning patient safety and improper infusion leading to severe consequences will hamper the growth of the market.
Geographically, the market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.
North America accounted for the largest market share in the Drug Delivery Infusion Systems market in 2017 owing to positive government regulations and reimbursement policies. Asia Pacific region recorded the highest growth rate because of rising healthcare expenditure and increasing patient awareness.
Significant players of the market are Acromed AG, B. Braun Melsungen AG, Baxter International, Becton Dickinson and Company, Caesarea Medical Electronics Ltd., Flowonix Medical Inc., Fresenius Kabi, IRADIMED CORPORATION, Medtronic, Others.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
